Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Erlotinib can cause hair loss and texture changes.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Vismodegib is effective for basal cell carcinoma but has severe side effects.